2020 annual financial data
Edgewise Therapeutics 2020 Net income growth
Direct answer
Net income growth was -79.78%.
Operating income was -17,192,000 USD and net income was -17,054,000 USD.
Operating cash flow was -14,634,000 USD.
Get free Edgewise Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,192,000 USD
- Net income
- -17,054,000 USD
- Operating cash flow
- -14,634,000 USD